Antibodies are naturally made in our bodies to fight infection. Without antibodies, a virus can enter and infect a cell. With antibodies, however, when the virus tries to enter the cell, antibodies block the virus. Monoclonal antibodies (mAbs) are antibodies developed in a laboratory to help our bodies fight infection. Nearly 100 mAbs are FDA-approved to treat health conditions including cancers and autoimmune diseases.
Monoclonal antibodies are also being studied for the treatment and prevention of COVID-19. They are given through intravenous infusion (i.e., through a vein) or injection. How often infusions or injections of mAbs are needed depends on the specific mAbs. Common side effects of mAb treatment can be allergic reactions, flu-like symptoms, nausea and vomiting, diarrhea, or low blood pressure.
We need your help to keep learning and improving vaccines against COVID-19. We made history with safe and effective vaccines and we’ll keep working as long as there are people to protect, variants emerging, and research answers needed to end this pandemic. To participate:
Content last reviewed on May 12, 2021